SCHEMBL12426765

SCHEMBL12426765

NCC(=O)N1CCCC2CN(C(=O)c3ccc(N)nc3)CC21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT5A Q9NQR1 1/20 0.39
JAK3 P52333 1/20 0.38
L3MBTL3 Q96JM7 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
SCN9A Q15858 2/20 0.37
DPP4 P27487 1/20 0.37
PREP P48147 1/20 0.37
FAP Q12884 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
ADRA1A P35348 3/20 0.37
PIK3CA P42336 2/20 0.36
MTOR P42345 2/20 0.36
HPGD P15428 1/20 0.36
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12425779 0.87 KMT5A (0.43) KMT5AL3MBTL3L3MBTL1ADRA1APIK3CA
SCHEMBL12425803 0.82 DPP4 (0.43) KMT5AL3MBTL3L3MBTL1DPP4PREP
SCHEMBL12425614 0.82 PIK3CA (0.50) KMT5APIK3CAMTOR
SCHEMBL12425408 0.82 PIK3CA (0.41) KMT5AJAK3SCN9ADPP4PREP
SCHEMBL12426766 0.78 PIK3CA (0.46) PIK3CAMTORLMNA
SCHEMBL12425620 0.74 CYP3A4 (0.41) PIK3CAMTOR
SCHEMBL12425404 0.72 L3MBTL3 (0.51) L3MBTL3L3MBTL1PIK3CAMTORHPGD
SCHEMBL12425600 0.71 CHRNA4 (0.60) L3MBTL3L3MBTL1GABRPGABRDGABRA1
SCHEMBL6173203 0.70 HPGD (0.59) L3MBTL3L3MBTL1HPGDGABRPGABRD
SCHEMBL10726108 0.69 HPGD (0.61) L3MBTL3L3MBTL1HPGDGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101409-A1 PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 NOVARTIS AG (CH) 2011-08-25 WO disclosed